Parmax Pharma Ltd
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 10.30 | 3.34 | 4.33 |
| Operating Expense | 7.39 | 4.86 | 4.52 |
| Net Profit | 2.20 | -0.58 | -0.73 |
| Net Profit Margin | 21.36% | -17.37% | -16.86% |
| Earning Per Share | 5.88 | -1.56 | -1.96 |
| EBIDTA | 2.91 | 0.17 | -0.18 |
| Effective Tax Rate | 0% | -0% | -0% |
Particulars
Jun 2026
Revenue10.30
Operating Expense7.39
Net Profit2.20
Net Profit Margin21.36
Earning Per Share5.88
EBIDTA2.91
Effective Tax Rate0
